Tiragolumab ELISA Kit

Description of Tiragolumab ELISA Kit

The Structure of Tiragolumab ELISA Kit

Tiragolumab ELISA Kit is a highly specific and sensitive tool for the detection and quantification of Tiragolumab, a monoclonal antibody targeting a novel immune checkpoint protein. The kit is designed for use in research and clinical laboratories, providing a reliable and accurate method for measuring the levels of Tiragolumab in various biological samples.
The kit contains all the necessary components for performing an enzyme-linked immunosorbent assay (ELISA) including pre-coated microplates, standards, controls, and detection reagents. The microplates are coated with a capture antibody that specifically binds to Tiragolumab, while the detection reagents consist of a biotinylated detection antibody and an enzyme-conjugated streptavidin. The streptavidin-enzyme complex reacts with a substrate to produce a colorimetric signal, which is directly proportional to the amount of Tiragolumab present in the sample.
The structure of Tiragolumab ELISA Kit allows for a simple and user-friendly workflow, with minimal hands-on time and a short incubation period. The kit is also available in a variety of formats including 96-well and 384-well plates, allowing for flexibility in sample size and throughput.

The Activity of Tiragolumab ELISA Kit

Tiragolumab ELISA Kit has been extensively validated for its specificity, sensitivity, and precision. The kit has a low limit of detection, with the ability to detect Tiragolumab at concentrations as low as 0.1 ng/mL. It also has a wide dynamic range, allowing for the accurate quantification of Tiragolumab in a variety of sample types.
The activity of Tiragolumab ELISA Kit is based on the principle of competitive ELISA, where the amount of Tiragolumab present in the sample competes with a fixed amount of biotinylated Tiragolumab for binding to the capture antibody. The colorimetric signal produced is inversely proportional to the amount of Tiragolumab in the sample, allowing for precise quantification.
The kit also demonstrates excellent intra- and inter-assay variability, ensuring reproducibility and reliability of results. It has been tested and validated for use with various sample types including serum, plasma, and cell culture supernatants, making it a versatile tool for researchers and clinicians.

The Application of Tiragolumab ELISA Kit

Tiragolumab is a promising therapeutic target in the field of cancer immunotherapy. It is a monoclonal antibody that binds to TIGIT, a protein expressed on immune cells that inhibits their function. By blocking TIGIT, Tiragolumab enhances the anti-tumor immune response, making it a potential treatment option for various types of cancer.
Tiragolumab ELISA Kit is a valuable tool for studying the pharmacokinetics and pharmacodynamics of Tiragolumab in preclinical and clinical settings. It can be used to measure the levels of Tiragolumab in patient samples, providing insights into drug efficacy and potential biomarkers for response to treatment.
The kit can also be used in drug development and quality control, ensuring the accurate and consistent measurement of Tiragolumab levels in different formulations and batches. Additionally, Tiragolumab ELISA Kit can be used in basic research to investigate the role of TIGIT in cancer and other diseases, as well as in the development of new therapeutics targeting this immune checkpoint.

In Conclusion

Tiragolumab ELISA Kit is a powerful tool for the detection and quantification of Tiragolumab, a promising therapeutic antibody targeting TIGIT. Its unique structure, high activity,